Products
Galenoderm, a chemical-pharmaceutical company based in Slovakia, focuses on the development, production, and marketing of active pharmaceutical ingredients (APIs) and chemical intermediates and specialties.
The company is export-oriented, with about 90% of its total sales coming from international markets including Europe, the USA, and selected Asian countries. Recent expansions include territories like Latin America, Russia, and Japan. Galenoderm also has a stable market presence domestically. It actively participates in major industry trade fairs such as CPhI Worldwide and DCAT in New York to support its sales activities.
Production involves the synthesis of heterocyclic compounds using common chemical reactions, including Grignard reactions, in facilities that adhere to good manufacturing practices (GMP). This production takes place in enamelled and stainless steel reactors with capacities up to 6300 liters, supported by various auxiliary production equipment. The final stages of production include sieving, grinding, potential micronization, and packaging, with production units undergoing regular inspections by the Slovak Health Authority (SÚKL) and some subject to FDA audits.
